| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6388555
[patent_doc_number] => 20100317675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => '6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828374
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828374 | 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof | Jun 30, 2010 | Issued |
Array
(
[id] => 6388646
[patent_doc_number] => 20100317685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION'
[patent_app_type] => utility
[patent_app_number] => 12/828369
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6544
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317685.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828369 | N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | Jun 30, 2010 | Abandoned |
Array
(
[id] => 6388675
[patent_doc_number] => 20100317688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => '2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828388
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8581
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317688.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828388 | 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Jun 30, 2010 | Abandoned |
Array
(
[id] => 6388531
[patent_doc_number] => 20100317673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION'
[patent_app_type] => utility
[patent_app_number] => 12/828370
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13317
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828370 | N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | Jun 30, 2010 | Abandoned |
Array
(
[id] => 6388657
[patent_doc_number] => 20100317686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828376
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21558
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828376 | N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Jun 30, 2010 | Abandoned |
Array
(
[id] => 6387941
[patent_doc_number] => 20100317620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828384
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6845
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828384 | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF | Jun 30, 2010 | Abandoned |
Array
(
[id] => 7774442
[patent_doc_number] => 08119657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods'
[patent_app_type] => utility
[patent_app_number] => 12/820993
[patent_app_country] => US
[patent_app_date] => 2010-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14373
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119657.pdf
[firstpage_image] =>[orig_patent_app_number] => 12820993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/820993 | Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods | Jun 21, 2010 | Issued |
Array
(
[id] => 6134386
[patent_doc_number] => 20110008288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'HEPATITIS C VIRUS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/816171
[patent_app_country] => US
[patent_app_date] => 2010-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25179
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008288.pdf
[firstpage_image] =>[orig_patent_app_number] => 12816171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/816171 | Hepatitis C virus inhibitors | Jun 14, 2010 | Issued |
Array
(
[id] => 8146910
[patent_doc_number] => 08163920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Quinolinone-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 12/815672
[patent_app_country] => US
[patent_app_date] => 2010-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25899
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163920.pdf
[firstpage_image] =>[orig_patent_app_number] => 12815672
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/815672 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Jun 14, 2010 | Issued |
Array
(
[id] => 6351094
[patent_doc_number] => 20100249183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'THERAPEUTIC USE OF N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/815593
[patent_app_country] => US
[patent_app_date] => 2010-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20588
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12815593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/815593 | THERAPEUTIC USE OF N-(ARYLALKYL)-1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES | Jun 14, 2010 | Abandoned |
Array
(
[id] => 6380290
[patent_doc_number] => 20100316649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'SMALL MOLECULE INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)'
[patent_app_type] => utility
[patent_app_number] => 12/815159
[patent_app_country] => US
[patent_app_date] => 2010-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56137
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12815159
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/815159 | Small molecule inhibitors of spleen tyrosine kinase (SYK) | Jun 13, 2010 | Issued |
Array
(
[id] => 6149964
[patent_doc_number] => 20110021559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES'
[patent_app_type] => utility
[patent_app_number] => 12/792044
[patent_app_country] => US
[patent_app_date] => 2010-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13943
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12792044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/792044 | Aminopyridines useful as inhibitors of protein kinases | Jun 1, 2010 | Issued |
Array
(
[id] => 8760298
[patent_doc_number] => 08420819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization'
[patent_app_type] => utility
[patent_app_number] => 12/788562
[patent_app_country] => US
[patent_app_date] => 2010-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8284
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/788562 | Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization | May 26, 2010 | Issued |
Array
(
[id] => 8533421
[patent_doc_number] => 08309575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Quinolinone-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 12/782915
[patent_app_country] => US
[patent_app_date] => 2010-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25869
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12782915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782915 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | May 18, 2010 | Issued |
Array
(
[id] => 8642843
[patent_doc_number] => 08367830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins'
[patent_app_type] => utility
[patent_app_number] => 13/321122
[patent_app_country] => US
[patent_app_date] => 2010-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 16
[patent_no_of_words] => 14204
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321122 | Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins | May 13, 2010 | Issued |
Array
(
[id] => 8043443
[patent_doc_number] => 20120071469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'NOVEL 1,4-DIAZA-BICYCLO[3.2.1]OCTANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/319936
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5923
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071469.pdf
[firstpage_image] =>[orig_patent_app_number] => 13319936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319936 | NOVEL 1,4-DIAZA-BICYCLO[3.2.1]OCTANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | May 11, 2010 | Abandoned |
Array
(
[id] => 8301974
[patent_doc_number] => 20120184525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => '1,2,3-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THIER USE FOR THE TREATMENT OF PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/319541
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67050
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319541
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319541 | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders | May 10, 2010 | Issued |
Array
(
[id] => 8301968
[patent_doc_number] => 20120184527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => '1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 13/319558
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28890
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319558 | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors | May 10, 2010 | Issued |
Array
(
[id] => 8128479
[patent_doc_number] => 20120088789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/319955
[patent_app_country] => US
[patent_app_date] => 2010-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5938
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088789.pdf
[firstpage_image] =>[orig_patent_app_number] => 13319955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319955 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | May 5, 2010 | Issued |
Array
(
[id] => 9183958
[patent_doc_number] => 08623890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Nematocidal sulfonamides'
[patent_app_type] => utility
[patent_app_number] => 13/264159
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49744
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264159 | Nematocidal sulfonamides | May 3, 2010 | Issued |